Moreover, the baseline risk of hyperprolactinemia might be high in Japan due to the fact that prolactin-raising antipsychotics (i.e., risperidone and first-generation antipsychotics) are commonly prescribed to children and adolescents (Inoue et al. 2017). This evidence concerns the gene PRL and hyperprolactinemia.